Pressure BioSciences Inc. (PBIO) Financials Nov 14
Post# of 250675
Posted On: 11/17/2014 4:51:16 AM
Pressure BioSciences Inc. (PBIO) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Pressure BioSciences Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.24M 1.34M 987,729 1.24M 1.5M
Cost of Goods Sold (COGS) incl. D&A 402,340 376,514 342,865 416,415 567,828
COGS excluding D&A 197,999 179,083 201,550 308,894 488,265
Depreciation & Amortization Expense 204,341 197,431 141,315 107,521 79,563
Depreciation 155,709 148,799 92,683 58,889 30,931
Amortization of Intangibles 48,632 48,632 48,632 48,632 48,632
Gross Income 842,570 963,518 644,864 821,802 935,460
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.04M 4.36M 3.94M 4.29M 4.26M
Research & Development 1.18M 1.23M 969,473 965,623 1.04M
Other SG&A 2.86M 3.13M 2.97M 3.32M 3.23M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 (430,423) (144,840) (113,713)
EBIT after Unusual Expense 0 0 430,423 144,840 113,713
Non Operating Income/Expense 0 244,479 0 0 (531,130)
Non-Operating Interest Income 4,990 2,303 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 0 0 136,595 133,417 339,818
Gross Interest Expense 0 0 136,595 133,417 339,818
Interest Capitalized - - - 0 0
Pretax Income (3.19M) (3.15M) (3M) (3.45M) (4.08M)
Income Tax (623,262) (23,710) 0 (2,014) 0
Income Tax - Current Domestic - - 0 - -
Income Tax - Current Foreign - - 0 - -
Income Tax - Deferred Domestic - - 0 - -
Income Tax - Deferred Foreign - - 0 - -
Income Tax Credits - - 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) - - 18,896 0 0
Consolidated Net Income (2.57M) (3.13M) (2.98M) (3.45M) (4.08M)
Minority Interest Expense 0 0 0 0 0
Net Income (2.57M) (3.13M) (2.98M) (3.45M) (4.08M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.57M) (3.13M) (2.98M) (3.45M) (4.08M)
Preferred Dividends 716,463 502,564 2.13M 950,010 1.16M
Net Income Available to Common (3.28M) (3.63M) (5.11M) (4.4M) (5.25M)
EPS (Basic) (1.42) (1.35) (0.77) (0.43) (0.44)
Basic Shares Outstanding 2.31M 2.69M 6.62M 10.15M 11.82M
EPS (Diluted) (1.42) (1.35) (0.77) (0.43) (0.44)
Diluted Shares Outstanding 2.31M 2.69M 6.62M 10.15M 11.82M
EBITDA (2.99M) (3.2M) (3.15M) (3.36M) (3.25M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Pressure BioSciences Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.24M 1.34M 987,729 1.24M 1.5M
Cost of Goods Sold (COGS) incl. D&A 402,340 376,514 342,865 416,415 567,828
COGS excluding D&A 197,999 179,083 201,550 308,894 488,265
Depreciation & Amortization Expense 204,341 197,431 141,315 107,521 79,563
Depreciation 155,709 148,799 92,683 58,889 30,931
Amortization of Intangibles 48,632 48,632 48,632 48,632 48,632
Gross Income 842,570 963,518 644,864 821,802 935,460
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.04M 4.36M 3.94M 4.29M 4.26M
Research & Development 1.18M 1.23M 969,473 965,623 1.04M
Other SG&A 2.86M 3.13M 2.97M 3.32M 3.23M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 (430,423) (144,840) (113,713)
EBIT after Unusual Expense 0 0 430,423 144,840 113,713
Non Operating Income/Expense 0 244,479 0 0 (531,130)
Non-Operating Interest Income 4,990 2,303 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 0 0 136,595 133,417 339,818
Gross Interest Expense 0 0 136,595 133,417 339,818
Interest Capitalized - - - 0 0
Pretax Income (3.19M) (3.15M) (3M) (3.45M) (4.08M)
Income Tax (623,262) (23,710) 0 (2,014) 0
Income Tax - Current Domestic - - 0 - -
Income Tax - Current Foreign - - 0 - -
Income Tax - Deferred Domestic - - 0 - -
Income Tax - Deferred Foreign - - 0 - -
Income Tax Credits - - 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) - - 18,896 0 0
Consolidated Net Income (2.57M) (3.13M) (2.98M) (3.45M) (4.08M)
Minority Interest Expense 0 0 0 0 0
Net Income (2.57M) (3.13M) (2.98M) (3.45M) (4.08M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.57M) (3.13M) (2.98M) (3.45M) (4.08M)
Preferred Dividends 716,463 502,564 2.13M 950,010 1.16M
Net Income Available to Common (3.28M) (3.63M) (5.11M) (4.4M) (5.25M)
EPS (Basic) (1.42) (1.35) (0.77) (0.43) (0.44)
Basic Shares Outstanding 2.31M 2.69M 6.62M 10.15M 11.82M
EPS (Diluted) (1.42) (1.35) (0.77) (0.43) (0.44)
Diluted Shares Outstanding 2.31M 2.69M 6.62M 10.15M 11.82M
EBITDA (2.99M) (3.2M) (3.15M) (3.36M) (3.25M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)